Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Developmental Therapeutics Program Resource Report Resource Website 500+ mentions |
Developmental Therapeutics Program (RRID:SCR_003057) | DTP | data or information resource, topical portal, service resource, portal, funding resource | Portal for preclinical information and research materials, including web-accessible data and tools, NCI-60 Tumor Cell Line Screen, compounds in vials and plates, tumor cells, animals, and bulk drugs for investigational new drug (IND)-directed studies. DTP has been involved in the discovery or development of more than 70 percent of the anticancer therapeutics on the market today, and will continue helping the academic and private sectors to overcome various therapeutic development barriers, particularly through supporting high-risk projects and therapeutic development for rare cancers. Initially DTP made its drug discovery and development services and the results from the human tumor cell line assay publicly accessible to researchers worldwide. At first, the site offered in vitro human cell line data for a few thousand compounds and in vitro anti-HIV screening data for roughly 42,000 compounds. Today, visitors can find: * Downloadable in vitro human tumor cell line data for some 43,500 compounds and 15,000 natural product extracts * Results for 60,000 compounds evaluated in the yeast assay * In vivo animal model results for 30,000 compounds * 2-D and 3-D chemical structures for more than 200,000 compounds * Molecular target data, including characterizations for at least 1,200 targets, plus data from multiple cDNA microarray projects In addition to browsing DTP's databases and downloading data, researchers can request individual samples or sets of compounds on 96-well plates for research, or they can submit their own compounds for consideration for screening via DTP's online submission form. Once a compound is submitted for screening, researchers can follow its progress and retrieve data using a secure web interface. The NCI has collected information on almost half a million chemical structures in the past 50 years. DTP has made this information accessible and useful for investigators through its 3-D database, a collection of three-dimensional structures for more than 200,000 drugs. Investigators use the 3-D database to screen compounds for anticancer therapeutic activity. Also available on DTP's website are 127,000 connection tables for anticancer agents. A connection table is a convenient way of depicting molecular structures without relying on drawn chemical structures. As unique lists of atoms and their connections, the connection tables can be indexed and stored in computer databases where they can be used for patent searches, toxicology studies, and precursor searching, for example., THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025. | cell line, drug discovery, drug development, drug, treatment, therapy, biopharmaceutical, bortezomib, paclitaxel, romidepsin, eribulin, sipuleucel-t, anticancer therapeutic, compound, natural product extract, animal model, in vivo, in vitro, chemical structure, chemical, structure, anti-hiv, anticancer, molecular structure, database, chemotherapeutic agent, testing, drug synthesis, chemistry, grant, contract, information technology, molecular pharmacology, natural product, pharmaceutical, screening technology, toxicology, pharmacology, screening, FASEB list |
is used by: NIF Data Federation is related to: Integrated Cell Lines has parent organization: National Cancer Institute |
Cancer, Tumor | NCI | THIS RESOURCE IS NO LONGER IN SERVICE | nif-0000-30447 | https://medschool.cuanschutz.edu/colorado-cancer-center/research/research-programs/developmental-therapeutics | SCR_003057 | Developmental Therapeutics Program NCI/NIH | 2026-08-08 11:57:52 | 571 | ||||
|
mutationSeq Resource Report Resource Website 10+ mentions |
mutationSeq (RRID:SCR_006815) | mutationSeq | software resource | A software suite using feature-based classifiers for somatic mutation prediction from paired tumour/normal next-generation sequencing data. mutationSeq has the advantages of integrating different features (e.g., base qualities, mapping qualities, strand bias, and tailed distance features), and validated somatic mutations to make predictions. Given paired normal/tumour bam files, mutationSeq will output the probability of each candidate site being somatic. | next-generation sequencing, somatic mutation, tumor, normal |
is listed by: OMICtools is related to: JointSNVMix has parent organization: BC Cancer Agency |
Tumor, Normal | PMID:22084253 | OMICS_00086 | SCR_006815 | 2026-08-08 11:59:02 | 24 | |||||||
|
Althia Resource Report Resource Website |
Althia (RRID:SCR_003918) | Althia | commercial organization | A biomedical company in Spain focused on the development of new tools for diagnosis and personalized treatment of oncological diseases and precancerous. It has three areas of activity in permanent innovation: Assistance in Diagnosis / Prognosis in solid and hematological tumors, Translational Research covering the gap between basic and clinical research and advanced radiotherapy treatments based image-guided single dose (SD-IGRT). Their objectives are: * Provide an integrated tissue and tumor molecular phenotype analysis using the most advanced technologies in diagnosis, to guide the most appropriate treatment for each patient. * Discover and validate molecular patterns by molecular systems and platforms including pathology, to generate predictive algorithms through computational biology, evolution and determining the response of patients with a particular tumor profile. Althia has laboratories equipped with the most advanced equipment and technologies in Barcelona and Granada Genyo Center, with offices in Madrid. | oncology, diagnosis, prognosis, solid tumor, hematological tumor, translational, radiation, phenotype, analysis, pathology, hematology, hereditary | is related to: PRECISESADS | Cancer, Tumor, Solid tumor, Hematological tumor, Precancer | nlx_158279 | SCR_003918 | Althia Health Ltd., Althia Health, Advanced Laboratories of Translational Health, SL, S.L. | 2026-08-08 11:58:09 | 0 | |||||||
|
Experimental Pharmacology and Oncology Berlin-Buch Resource Report Resource Website 1+ mentions |
Experimental Pharmacology and Oncology Berlin-Buch (RRID:SCR_003954) | EPO | commercial organization | A small and medium-sized enterprise (SME) that has expertise in preclinical pharmacology, pharmacokinetics, and toxicology for the characterization of novel anticancer therapeutics and predictive biomarkers like: cytostatics, biologicals (peptides, antibodies), (anti)-hormones, immunomodulators (cytokines), and gene therapeutics. EPO has modern laboratories licensed for animal experiments and gene technology (S2) and a broad panel of murine and human tumor models growing in immunocompetent (SPF-quality, syngeneic strains) or immunodeficient mice (nude, SCID, NOD/SCID). EPO has established imaging technologies to monitor in vivo tumor growth. | tumor model, pharmaceutical, oncology, in vitro, in vivo, antitumor, preclinical, pharmacology, pharmacokinetics, toxicology, anticancer, therapeutic, biomarker, imaging, testing, validation, target | is related to: OncoTrack | Tumor, Cancer | nlx_158355 | SCR_003954 | EPO - Experimental Pharmacology & Oncology GmbH, Experimental Pharmacology & Oncology GmbH, Experimental Pharmacology & Oncology Berlin-Buch, Experimental Pharmacology & Oncology Berlin-Buch GmbH, EPO Berlin-Buch GmbH, EPO-GmbH | 2026-08-08 11:58:10 | 2 | |||||||
|
Alacris Theranostics Resource Report Resource Website |
Alacris Theranostics (RRID:SCR_003953) | Alacris | commercial organization | Commercial organization that uses next generation sequencing technologies coupled with computational modeling of tumor and somatic tissues in order to identify individualized therapies for cancer patients. The company also uses these technologies to help pharmaceutical partners stratify patients for their clinical trials. Alacris has an exclusive worldwide commercial license for the computational modeling of tumors and somatic tissues using proprietary computational systems modeling technologies ModCell developed at the Max Planck Institute for Molecular Genetics (MPI-MG) in Berlin coupled with next generation sequencing and genotyping technology developed at Harvard Medical School in Boston. The company also is building up the first next generation sequencing center in Europe for clinical operations. | next generation sequencing, computational modeling, clinical trial, somatic tissue, genotyping, genomics, oncogenomics, diagnostics, therapy, disease model, drug, personalized medicine, biomarker, drug development, tumor model, analysis, oncology | is related to: OncoTrack | Tumor, Cancer | nlx_158354, grid.473915.d | https://ror.org/04a0gnr15 | SCR_003953 | Alacris Theranostics GmbH | 2026-08-08 11:58:07 | 0 | ||||||
|
Canadian Virtual Brain Tumour Bank Resource Report Resource Website |
Canadian Virtual Brain Tumour Bank (RRID:SCR_004221) | CVBTB | biomaterial supply resource, material resource, tissue bank, brain bank | THIS RESOURCE IS NO LONGER IN SERVICE, documented May 10, 2017. The mission of the Canadian Virtual Brain Tumour Bank (CVBTB) is to facilitate clinical, molecular and translational research through the provision of well-characterized tissue linked to clinical data and to become a standardized national tissue resource whereby scientific needs are met, addressed and accelerated through a common public accessible core the CVBTB. Recognizing the need to encourage systemic banking of brain tumor tissues throughout the country and to link banks of brain tumor tissue samples with academic and scientific institutions that require these samples, the CVBTB was established. Under the sponsorship of Schering Plough Canada Inc. and in association with the Canadian Brain Tumour Consortium (CBTC), the CVBTB looks to act as a resource for all researchers to provide them with information on the types of brain tumor tissue samples available and to direct them to the tumor tissue banking sites holding these samples. The CVBTB also looks to provide information on standard operating procedures regarding aspects of tumor tissue banking such as tissue accrual, storage and shipment and the processing of blood samples such as serum and lymphocytes. The CVBTB currently consists of four brain tumour tissue banking sites (Toronto Western Hospital - Toronto, Ontario; London Health Sciences Centre - London, Ontario; McGill University - Montreal, Quebec; University of Calgary - Calgary, Alberta) and is continuously looking for more institutions to be a part of the CVBTB. If your institution would like to become a part of the CVBTB, please contact the CVBTB coordinator. | virtual tissue bank, brain tumor, tumor bank, standardized tissue bank |
is listed by: One Mind Biospecimen Bank Listing has parent organization: University of Toronto; Ontario; Canada |
Tumor | Schering Plough Canada Inc. | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_24047 | SCR_004221 | Canadian Virtual Brain Tumor Bank | 2026-08-08 11:58:18 | 0 | |||||
|
Mutascope Resource Report Resource Website 1+ mentions |
Mutascope (RRID:SCR_001265) | Mutascope | software resource, software application, data analysis software, data processing software | Software suite to analyze data from high throughput sequencing of PCR amplicons, with an emphasis on normal-tumor comparison for the accurate and sensitive identification of low prevalence mutations. | high throughput sequencing, pcr amplicon, pcr, mutation, amplicon, sequencing, somatic variant |
is listed by: OMICtools has parent organization: SourceForge |
Tumor, Normal | PMID:23712659 | Free, Public | OMICS_02074 | SCR_001265 | Mutascope - Analysis software designed for PCR-amplicon sequencing data | 2026-08-08 11:57:39 | 4 | |||||
|
QuadGT Resource Report Resource Website 1+ mentions |
QuadGT (RRID:SCR_000073) | QuadGT | software resource | Software package for calling single-nucleotide variants in four sequenced genomes comprising a normal-tumor pair and the two parents. Genotypes are inferred using a joint model of parental variant frequencies, de novo germline mutations, and somatic mutations. The model quantifies the descent-by-modification relationships between the unknown genotypes by using a set of parameters in a Bayesian inference setting. Note that you can use it on any subset of the four related genomes, including parent-offspring trios, and normal-tumor pairs without parental samples. | single-nucleotide variant, sequenced genome, genotype, genome |
is listed by: OMICtools has parent organization: University of Montreal; Quebec; Canada |
Normal, Tumor, Cancer | Terry Fox Research Institute ; Canadian Institutes for Health Research ; Canada National Sciences and Engineering Research Council |
PMID:23734724 | Free, Available for download, Freely available | OMICS_02108 | SCR_000073 | 2026-08-08 11:57:12 | 1 | |||||
|
deStruct Resource Report Resource Website 1+ mentions |
deStruct (RRID:SCR_004747) | deStruct | software resource | A software tool for identifying structural variation in tumour genomes from whole genome illumina sequencing. | structural variation, genome, genomics |
is listed by: OMICtools has parent organization: Google Code |
Tumor, Cancer | Open unspecified license | OMICS_00314 | SCR_004747 | deStruct - Bioinformatics tool for identifying structural variation in tumour genomes | 2026-08-08 11:58:26 | 8 | ||||||
|
Andalusian Regional Tumour Bank Resource Report Resource Website |
Andalusian Regional Tumour Bank (RRID:SCR_004885) | biomaterial supply resource, material resource, tissue bank | THIS RESOURCE IS NO LONGER IN SERVICE, documented on July 16, 2013. Located in Spain, the Andalusian Regional Tumour Bank is a regional tumor bank. In the last decades cancer knowledge is growing exponentially due human genome knowledge and technological advantages. However, this disease is the biggest problem of health in Europe, with more than 2,5 million new cases per year. The diagnosis and treatment of cancer is now allowing to identify the characteristics that the disease has on each person. The next step is meant to be a great revolution in the treatment of cancer. This scientific development is dependent on the availability of human tumour samples preserved in demanding conditions. Current technology requires the availability of tissue morphological and molecular conditions similar to those that had the sample before being removed. Tumor banks are responsible for these new quality requirements to foster the development of research and health care of patients. | tumor tissue, tissue, tumor, cancer | is listed by: One Mind Biospecimen Bank Listing | Tumor, Cancer | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_85675 | SCR_004885 | Andalusian Regional Tumor Bank, Red de Bancos de Tumores de Andalucia | 2026-08-08 12:03:49 | 0 | |||||||
|
Boston University Biospecimen Archive Research Core Resource Report Resource Website 1+ mentions |
Boston University Biospecimen Archive Research Core (RRID:SCR_005363) | BU BARC | biomaterial supply resource, material resource, tissue bank | Biospecimen repository of normal and diseased human material from a variety of tissues and conditions along with clinical annotation. Both frozen aliquots and paraffin embedded tissue are available. Biospecimens are available to qualified researchers with IRB approval. * Preliminary inquires please contact Cheryl Spencer at cheryl.spencer (at) bmc.org | disease, normal, cancer, tumor, colon, inflammatory bowel disease, rectal cancer, colon cancer, tonsil, obstructive sleep apnea, tonsillitis, parathyroid, parathyroid adenoma, stomach, stomach cancer, prostate, prostate cancer, uterus, uterine cancer, lung, squamous cell carcinoma, adenocarcinoma, ovary, ovarian cancer, thyroid, thyroid papillary carcinoma, kidney, papillary renal cell carcinoma, renal cell carcinoma, clear cell carcinoma, breast, ductal carcinoma in situ, invasive ductal carcinoma, invasive lobular carcinoma, tissue, cancer tissue, colon tissue, tonsil tissue, parathyroid tissue, stomach tissue, prostate tissue, uterine tissue, lung tissue, ovarian tissue, thyroid tissue, kidney tissue, breast tissue, frozen, paraffin block, blood, biopsy, heart disease, diabetes, brain, brain tissue, adrenal, adrenal tissue, parotid, parotid tissue, thymus, pancreas, cervix, esophagus, thymus tissue, pancreatic tissue, cervical tissue, esophageal tissue |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Boston University Medical Campus; Massachusetts; USA has parent organization: Boston University School of Medicine; Massachusetts; USA |
Disease, Cancer, Tumor, Normal, Heart disease, Diabetes, Inflammatory bowel disease, Rectal cancer, Colon cancer, Obstructive sleep apnea, Tonsillitis, Parathyroid adenoma, Stomach cancer, Prostate cancer, Uterine cancer, Squamous cell carcinoma, Adenocarcinoma, Ovarian cancer, Thyroid papillary carcinoma, Papillary renal cell carcinoma, Renal cell carcinoma, Clear cell carcinoma, Ductal carcinoma in situ, Invasive ductal carcinoma, Invasive lobular carcinoma | Public: The mission of the Biospecimen Archive Research Core (BARC) is to collect high quality samples of normal and diseased human material with appropriate clinical annotation and make these materials, Known as biospecimens, Available to qualified researchers while ensuring the informed consent, Safety and anonymity of all providers. | nlx_144430 | SCR_005363 | BU Biospecimen Archive Research Core, Boston University Biospecimen Archive Research Core (BARC), Biospecimen Archive Research Core Boston University Medical Center, Boston University Medical Center Biospecimen Archive Research Core, BUMC BARC, BUMC Biospecimen Archive Research Core | 2026-08-08 12:04:03 | 1 | ||||||
|
Einstein-Montefiore Institute for Clinical and Translational Research Biorepository Resource Report Resource Website 1+ mentions |
Einstein-Montefiore Institute for Clinical and Translational Research Biorepository (RRID:SCR_005297) | Einstein-Montefiore ICTR Biorepository | biomaterial supply resource, material resource, tissue bank | Patient-derived specimens are essential to research in genomics, proteomics, and biomarkers. We provide banking for biological fluid and tissue specimens as well as human DNA and RNA. We provide secure archival sample storage as well as clinically-annotated specimen biobanks for defined research projects. The core serves the human research blood and tissue banking needs of clinical and translational researchers. Samples can be banked by an individual PI or by a consortium of investigators. All samples are tracked and archived using a secure tracking database, the Einstein-Montefiore Bio-Repository Databank (EM-BRED), http://informatics30.aecom.yu.edu/em-bred/default.aspx. EM-BRED provides qualified investigators with a solution to securely link patient specimens to clinical and pathological data. It consists of a user-friendly query engine that allows for comprehensive specimen search, and ultimately to build clinical annotations of relevance. The facility works under the best practices set out by NCI and ISBER (2006) for collection, storage, and retrieval of human biological materials for research. | blood, tissue, dna, rna, clinical data, pathological data, frozen, flash frozen, oct embedded, paraffin embedded, tumor, cancer, non-tumor, adenoma, biliary atresia, carcinoma, clm, liver disease, colorectal metastasis, cryptogenic, etoh, familial hypercholestrolemia, hepatic artery injury, hepatitis b, hepatitis c, primary sclerosing cholangitis, recurrent pyogenic cholangitis with hepatolithiasis, subacute fulminant hepatic failure drug toxicity, database |
is listed by: One Mind Biospecimen Bank Listing is related to: Einstein-Montefiore ICTR Research Informatics Core has parent organization: Albert Einstein College of Medicine; New York; USA has parent organization: Montefiore Medical Center; New York; USA |
Tumor, Cancer, Non-tumor, Adenoma, Biliary atresia, Carcinoma, CLM, Liver disease, Colorectal metastasis, Cryptogenic, ETOH, Familial hypercholestrolemia, Hepatic artery injury, Hepatitis B, Hepatitis C, Primary sclerosing cholangitis, Recurrent pyogenic cholangitis with hepatolithiasis, Subacute fulminant hepatic failure drug toxicity | Varying: The core serves the human research blood and tissue banking needs of clinical and translational researchers. Samples can be banked by an individual PI or by a consortium of investigators. Owners of the samples grant permission. | nlx_144342 | SCR_005297 | Einstein-Montefiore Bio-Repository Databank, Einstein-Montefiore Bio-Repository Databank (EM-BRED), Einstein-Montefiore Institute for Clinical Translational Research Biorepository, Einstein-Montefiore Institute for Clinical & Translational Research Biorepository, EM-BRED | 2026-08-08 12:04:03 | 1 | ||||||
|
British Columbia Breast Cancer Tumour Bank Resource Report Resource Website |
British Columbia Breast Cancer Tumour Bank (RRID:SCR_006671) | BREAST-TTR | biomaterial supply resource, material resource, tissue bank | The Molecular Oncology department hosts the breast cancer tumour tissue repository (BREAST-TTR), a project within the agency-wide tumour tissue repository. The BREAST-TTR comprises several important banks of breast tissues, contemporaneous as well as archival. The main banks are: * 3000 frozen breast cancers, linked to 15 year outcomes data from the BCCA Breast Cancer Outcomes Unit. This archival bank consists of frozen tissue, DNA and RNA, and a tissue microarray of the cases. * Live-cryopreserved cancers. At present around 50 individual cases of metastatic breast cancer, with tumour material cryopreserved for subsequent cell culture/xenograft work. * Comptemporary bank. Between the TTR in Victoria and the accrual site in Vancouver, approximately 1300 contemporaneous (within last 4 years) breast cancers with matched normal DNA and outcomes linkages. | breast cancer, tumor, tissue, breast tissue, frozen tissue, dna, rna, tissue microarray, live-cryopreserved cancer, metastatic breast cancer, cryopreserved, matched normal dna |
is listed by: One Mind Biospecimen Bank Listing has parent organization: BC Cancer Agency |
Breast cancer, Tumor, Metastatic breast cancer, Matched normal | nlx_50799 | http://molonc.bccrc.ca/?page_id=421 | SCR_006671 | British Columbia Breast Tumour Bank, Breast Cancer Tumour Tissue Repository, British Columbia Breast Cancer Tumour Tissue Repository, British Columbia Breast Cancer Tumor Tissue Repository | 2026-08-08 12:04:09 | 0 | ||||||
|
Internet Brain Segmentation Repository Resource Report Resource Website 10+ mentions |
Internet Brain Segmentation Repository (RRID:SCR_001994) | IBSR | data or information resource, data set | Data set of manually-guided expert segmentation results along with magnetic resonance brain image data. Its purpose is to encourage the development and evaluation of segmentation methods by providing raw test and image data, human expert segmentation results, and methods for comparing segmentation results. Please see the MediaWiki for more information. This repository is meant to contain standard test image data sets which will permit a standardized mechanism for evaluation of the sensitivity of a given analysis method to signal to noise ratio, contrast to noise ratio, shape complexity, degree of partial volume effect, etc. This capability is felt to be essential to further development in the field since many published algorithms tend to only operate successfully under a narrow range of conditions which may not extend to those experienced under the typical clinical imaging setting. This repository is also meant to describe and discuss methods for the comparison of results. | 3d model, anatomy, brainstem, cerebellum, cortex, gray matter, imaging, morphology, mri, segmentation, volume, white matter, adult human, male, child, image collection, application, magnetic resonance, os independent, php, quality metrics, segmentation, test data, web service |
is listed by: NeuroImaging Tools and Resources Collaboratory (NITRC) has parent organization: Harvard Medical School; Massachusetts; USA |
Normal, Tumor | NINDS 1 R01 NS34189-01 | Free, Available for download, Freely available | nif-0000-00032 | http://www.cma.mgh.harvard.edu/ibsr/ | SCR_001994 | 2026-08-08 12:05:41 | 25 | |||||
|
GSE4922 Resource Report Resource Website 100+ mentions |
GSE4922 (RRID:SCR_003557) | GSE4922 | data or information resource, data set | Curated data set of a study that investigated the expression profiles of 347 primary invasive breast tumors on Affymetrix microarrays. Three separate breast cancer cohorts were analyzed: 1) Uppsala (n=249), 2) Stockholm (n=58), 3) Singapore (n=40). The Uppsala and Singapore data can be accessed in GSE4922. The Stockholm cohort data can be accessed at GEO Series GSE1456. | adult human, expression profile, breast |
is related to: Gene Expression Omnibus has parent organization: RanchoBiosciences |
Cancer, Breast cancer, Tumor | Free, Public | nlx_157796 | SCR_003557 | 2026-08-08 12:05:48 | 111 | |||||||
|
Spanish National Tumour Bank Network Resource Report Resource Website |
Spanish National Tumour Bank Network (RRID:SCR_008707) | CNIO TBN | biomaterial supply resource, material resource, tissue bank | THIS RESOURCE IS NO LONGER IN SERVICE, documented August 29, 2016. The need to use human neoplastic tissue under ideal conditions is currently of particular importance due to the development molecular pathology techniques that allow large-scale studies of genetic expression that are also of clinical significance. The Tumour Bank Network (TBN), instigated and coordinated by the Molecular Pathology Programme (MMP) aims to respond to this need by the promoting of Tumour Banks in Spanish hospitals. This will be achieved through the application of homogeneous procedures for the collection, processing and storage of neoplastic and normal tissue samples in such a way as to make molecular studies possible, avoiding that avoid the intrinsic bias of multi-centre studies possible. These Hospital Tumour Banks are based within the Pathology Departments of the collaborating Hospitals, that are interconnected through a computer-based network. In this way, each Centre''s tissue remains in the Hospital itself, thereby playing a key role in the development of the welfare, teaching and research activities within the Hospital. At the same time, it represents a tool to encourage of multi-hospital cancer research and of cooperation between basic and clinical researchers, constituting important collaboration between biomedical disciplines. The design does not correspond to a Central Tumour Bank, but that of a cooperative and coordinated Network of Hospital Banks, based on simple, homogeneous and optimal tissue treatment protocols. This Network is promoted by the Centro Nacional de Investigaciones Oncologicas (CNIO), which thereby undertakes the work of coordinating the network, using and maintaining the database, adhering to quality control. The aim of the CNIO's TBN is to acquire neoplastic and control non-neoplastic material of all types of malignant neoplasias, in the form of tissue fixed in formalin and paraffin embedded, of samples that are unfixed or frozen according to conventional methods as set out in Annexe 1 and even, exceptionally as fresh tissue. When other types of samples are required to carry out a specific project, the central office of the TBN will draw up a protocol with the group leading the project for the collection and maintenance of the tissue and clinicopathological data required for the proposed research. These protocols will be disseminated among the Associated Hospitals in order to gather the previously agreed number cases. Basic data surrounding the processing and preservation conditions for each case will be sent to the central office of the Bank, which under no circumstances will reveal the identity of the patient. Any Spanish cancer research team will be able to request tissue from the Tissue Bank Network. Absolute priority will be afforded to projects whose principal researcher belongs to one of the Associated Centres of the TNB, to other institutions with special agreements concerning the exchange of samples, and to the CNIO's researchers. | clinical, neoplastic tissue, non-neoplastic tissue, tissue, fixed, formalin, paraffin embedded, unfixed, frozen, tumor, cancer, normal control |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Spanish National Cancer Research Center |
Tumor, Cancer, Normal control | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_10273 | http://www.cnio.es/ing/programas/progTumor01.asp | SCR_008707 | Spanish National Cancer Centre Tumour Bank Network, Spanish National Cancer Research Center Tumor Bank Network, Centro Nacional de Investigaciones Oncologicas Tumor Bank Network, Centro Nacional de Investigaciones Oncologicas Tumour Bank Network, CNIO Tumor Bank Network, CNIO Tumour Bank Network, Spanish National Cancer Center Tumor Bank Network | 2026-08-08 12:04:22 | 0 | |||||
|
Arizona Cancer Center Tumor Bank Resource Report Resource Website |
Arizona Cancer Center Tumor Bank (RRID:SCR_003544) | AZCC Tumor Bank | biomaterial supply resource, material resource, tissue bank | TACMASS collects, preserves, and banks biospecimens obtained from Arizona Cancer Center surgical patients who are seen by University Medical Center surgeons and oncologists. Biospecimens collected at the time of surgery include fresh surgical tissue, blood and urine. Serum, plasma and genomic DNA are harvested from the whole blood. AZCC Members and collaborators may request the use of banked biospecimens through TACMASS. The patient's surgeon or oncologist is responsible for consenting the patient for submission of surgical specimens to the AZCC BioRepository (IRB #06-0609-04, Setsuko Chambers, PI). The surgeon and the Department of Pathology attending physicians and residents are responsible for identifying appropriate tissue for banking that will not compromise pathological diagnosis. Tumor and/or normal adjacent tissue, identified by gross examination, that will not be needed for pathological diagnosis are preserved by fixing in formalin, snap freezing, and/or fixing in RNALater. Histological diagnosis is rendered on each piece of formalin-fixed and snap frozen tissue by Hematoxylin and Eosin staining (H&E). Everyone involved in submitting specimens to the Tumor Bank must maintain a current CITI Certification. |
is listed by: One Mind Biospecimen Bank Listing has parent organization: University of Arizona; Arizona; USA |
Cancer, Tumor | nlx_10808 | SCR_003544 | 2026-08-08 12:03:44 | 0 | |||||||||
|
Ludwig Boltzman Tumour Bank Resource Report Resource Website |
Ludwig Boltzman Tumour Bank (RRID:SCR_004322) | Ludwig Boltzmann Tumor Bank | biomaterial supply resource, material resource, tissue bank | As a basis for the experimental cluster projects, and for further future projects a collection of various biological specimens of cancer patients shall be established. All participating Ludwig Boltzmann Institutes (LBIs) are supplying biological specimens from tumor patients and clinical documentation. At the LBI for Gynecology and Gynecologic Oncology a tumor bank for biological specimens from gynecologic cancer patients already exists. All the procedures for sample processing and storage are well established. Existing equipment for storing tissue specimens at -196 degrees C can be used. Materials from the following malignant diseases are collected: Breast cancer Colorectal cancer Neuroendocrine tumors (NET) (Small cell lung cancer (SCLC) and Carcinoid tumors) Types of biological materials: Tissue (fresh frozen) Bone marrow Blood (serum/plasma/cell fractions) Pleural effusions Ascitic fluids Sputum Bronchial lavage Stool The biological specimens are initially processed at the respective LBIs or at their connected lab facilities. Enrichment of blood samples for disseminated tumor cells is done at the LBI for Gynecology and Gynecologic oncology. Long time storage of all materials is done at appropriate temperatures at the same institution. This LBI also coordinates the logistics. All relevant sample-specific and clinical data are surveyed at the respective LBIs and stored centralized in an on-line data bank in anonymized form, respecting all relevant regulations on data protection and security. | tissue, bone marrow, blood, serum, plasma, cell fraction, pleural effusion, ascitic fluid, sputum, bronchial lavage, stool, tumor cell, fresh frozen, frozen, tumor, cancer, breast cancer, colorectal cancer, neuroendocrine tumor, small cell lung cancer, carcinoid tumor, gynecologic cancer, clinical data, bodily fluid |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Ludwig Boltzmann Cluster Translationale Onkologie |
Tumor, Cancer, Breast cancer, Colorectal cancer, Neuroendocrine tumor, Small cell lung cancer, Carcinoid tumor, Gynecologic cancer | nlx_33431 | SCR_004322 | Ludwig Boltzmann Gesellschaft Tumor Bank | 2026-08-08 12:03:46 | 0 | |||||||
|
Biorepository Alliance of Georgia for Oncology Resource Report Resource Website |
Biorepository Alliance of Georgia for Oncology (RRID:SCR_004184) | BRAG-Onc | biomaterial supply resource, material resource, tissue bank |
THIS RESOURCE IS NO LONGER IN SERVICE, documented on July 17, 2013. The Georgia Cancer Specimen and Tissue Bank is committed to a safe and reliable supply of tissue and cell products for research purposes. Work has begun already to build the state tumor bank initiative with operating sites in several locations through the state. We are confident that our results will yield a strong program that will benefit all Georgians and contribute to significant advances in cancer research and knowledge. |
is listed by: One Mind Biospecimen Bank Listing | Cancer, Tumor | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_20991 | SCR_004184 | Bio-Repository Alliance of Georgia for Oncology, Georgia Cancer Specimen and Tissue Bank, Bio-Repository Alliance of Georgia for Oncology Tissue and Tumor Bank | 2026-08-08 12:03:45 | 0 | |||||||
|
Canadian Breast Cancer Foundation Tumor Bank Resource Report Resource Website 1+ mentions |
Canadian Breast Cancer Foundation Tumor Bank (RRID:SCR_004214) | CBCF TB | biomaterial supply resource, material resource, tissue bank | THIS RESOURCE IS NO LONGER IN SERVICE, documented May 18, 2022. A tumor bank that provides a large collection of cancer specimens, from breast and other cancers, annotated with clinical information. The CBCF TB enables researchers to address unanswered questions concerning the prognosis and treatment of breast cancer and other cancers. The CBCF TB website is also directed to participants interested in donating tumor tissue or blood. Biological specimens such as blood, urine, bone marrow, and ascites (fluid that sometimes collects in the abdomen) contain genetic information, just as tumor tissue does. These samples can be used in studies that may help researchers see how people with certain genetic make-ups respond to certain treatments. It can also explain why different people have different health problems. CBCF TB, formerly ARTB, was created by a merger of components of two existing Tumor-banking initiatives, the CLS Repository in Calgary and the Tumor bank of the PolyomX Program in Edmonton. | clinical information, clinical |
is listed by: One Mind Biospecimen Bank Listing is related to: Canadian Tumour Repository Network has parent organization: Canadian Breast Cancer Foundation |
Breast cancer, Tumor, Cancer | Canadian Breast Cancer Foundation ; Alberta Cancer Foundation |
THIS RESOURCE IS NO LONGER IN SERVICE | nlx_143637 | http://www.abtumorbank.com/ | SCR_004214 | Canadian Breast Cancer Foundation Alberta Research Tumor Bank, ARTB, CBCF Tumor Bank, Alberta Research Tumor Bank | 2026-08-08 12:03:53 | 3 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the ASWG Resources search. From here you can search through a compilation of resources used by ASWG and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that ASWG has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on ASWG then you can log in from here to get additional features in ASWG such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into ASWG you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
Welcome to the ASWG Community.
Our Information
